China to Accept Taiwan Clinical Trials for SFDA Approval

Taiwan and China are expected to sign a bilateral pharmaceutical agreement that will speed approval of Taiwanese drugs in China. Under the new rules, China will accept clinical trials conducted in Taiwan for SFDA approval of a drug in China. The agreement could cut five years from the China approval process for Taiwan pharmas. More details....